UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 87

Sortiert nach

A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer

Gynecologic oncology, 2019-08, Vol.154 (2), p.294-301

2019

Link zum Volltext

Verfügbarkeit prüfen

Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: A systematic review

Gynecologic oncology, 2012-05, Vol.125 (2), p.477-482

2012

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study

Journal of clinical oncology, 2020-06, Vol.38 (16), p.1814-1823

2020

Link zum Volltext

Verfügbarkeit prüfen

Classification of Tumor Epithelium and Stroma by Exploiting Image Features Learned by Deep Convolutional Neural Networks

Annals of biomedical engineering, 2018-12, Vol.46 (12), p.1988-1999

2018

Link zum Volltext

Verfügbarkeit prüfen

Management of the toxicities of common targeted therapeutics for gynecologic cancers

Gynecologic oncology, 2018-03, Vol.148 (3), p.591-600

2018

Link zum Volltext

Verfügbarkeit prüfen

The impact of obesity on surgical staging, complications, and survival with uterine cancer: A Gynecologic Oncology Group LAP2 ancillary data study

Gynecologic oncology, 2014-04, Vol.133 (1), p.23-27

2014

Link zum Volltext

Verfügbarkeit prüfen

Prediction of chemotherapy response in ovarian cancer patients using a new clustered quantitative image marker

Physics in medicine & biology, 2018-08, Vol.63 (15), p.155020-155020

2018

Link zum Volltext

Verfügbarkeit prüfen

A contemporary framework of health equity applied to gynecologic cancer care: A Society of Gynecologic Oncology evidenced-based review

Gynecologic oncology, 2018-04, Vol.149 (1), p.70-77

2018

Link zum Volltext

Verfügbarkeit prüfen

Olaparib: an oral PARP-1 and PARP-2 inhibitor with promising activity in ovarian cancer

Future oncology (London, England), 2015-03, Vol.11 (5), p.747

2015

Link zum Volltext

Verfügbarkeit prüfen

Applying Quantitative CT Image Feature Analysis to Predict Response of Ovarian Cancer Patients to Chemotherapy

Academic radiology, 2017-10, Vol.24 (10), p.1233-1239

2017

Link zum Volltext

Verfügbarkeit prüfen

NRG‐GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer

Cancer, 2024-04, Vol.130 (8), p.1234-1245

2024

Link zum Volltext

Verfügbarkeit prüfen

A contemporary analysis of epidemiology and management of vaginal intraepithelial neoplasia

American journal of obstetrics and gynecology, 2013-05, Vol.208 (5), p.410.e1-410.e6

2013

Link zum Volltext

Verfügbarkeit prüfen

Potential and mechanism of mebendazole for treatment and maintenance of ovarian cancer

Gynecologic oncology, 2021-01, Vol.160 (1), p.302-311

2021

Link zum Volltext

Verfügbarkeit prüfen

Developing a new radiomics-based CT image marker to detect lymph node metastasis among cervical cancer patients

Computer methods and programs in biomedicine, 2020-12, Vol.197, p.105759-105759, Article 105759

2020

Link zum Volltext

Verfügbarkeit prüfen

BRACAnalysis CDx as a companion diagnostic tool for Lynparza

Expert review of molecular diagnostics, 2015-09, Vol.15 (9), p.1111-1116

2015

Link zum Volltext

Verfügbarkeit prüfen

Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma – A multi-institutional cohort

Gynecologic oncology, 2017-02, Vol.144 (2), p.274-278

2017

Link zum Volltext

Verfügbarkeit prüfen

Consideration of older patients for enrollment in phase 1 clinical trials: Exploring treatment related toxicities and outcomes

Gynecologic oncology, 2018-04, Vol.149 (1), p.28-32

2018

Link zum Volltext

Verfügbarkeit prüfen

Primary and acquired platinum-resistance among women with high grade serous ovarian cancer

Gynecologic oncology, 2016-08, Vol.142 (2), p.225-230

2016

Link zum Volltext

Verfügbarkeit prüfen

PARP Inhibition in Ovarian Cancer: State of the Science

Gynecologic oncology, 2015, Vol.136 (1), p.8-10

2015

Link zum Volltext

Verfügbarkeit prüfen

Extending the platinum-free interval: The impact of omitting 2nd line platinum chemotherapy in intermediate platinum-sensitive ovarian cancer

Gynecologic oncology, 2019-11, Vol.155 (2), p.201-206

2019

Link zum Volltext

Verfügbarkeit prüfen

Circulating Tumor Cell-Free DNA Genes as Prognostic Gene Signature for Platinum Resistant Ovarian Cancer Diagnosis

Biomarker insights, 2022-03, Vol.17, p.11772719221088404-11772719221088404

2022

Link zum Volltext

Verfügbarkeit prüfen

The Risk of Umbilical Hernia and Other Complications with Laparoendoscopic Single-Site Surgery

Journal of minimally invasive gynecology, 2012, Vol.19 (1), p.40-45

2012

Link zum Volltext

Verfügbarkeit prüfen

Factors influencing clinical trial enrollment among ovarian cancer patients

Gynecologic oncology, 2017-09, Vol.146 (3), p.465-469

2017

Link zum Volltext

Verfügbarkeit prüfen

Highlights from the Society of Gynecologic Oncology 2015 Annual Meeting on Women's Cancer

Gynecologic oncology, 2015-07, Vol.138 (1), p.3-6

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(85)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(49)
Humans
(45)
Female
(44)
Oncology
(36)
Obstetrics & Gynecology
(34)
Aged
(28)
Middle Aged
(28)
Adult
(23)
Hematology, Oncology And Palliative Medicine
(23)
Obstetrics And Gynecology
(21)
Retrospective Studies
(19)
Aged, 80 And Over
(18)
Ovarian Cancer
(18)
Ovarian Neoplasms - Drug Therapy
(13)
Ovarian Neoplasms - Pathology
(10)
Prognosis
(9)
Adolescent
(8)
Antineoplastic Agents - Therapeutic Use
(7)
Chemotherapy
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer

Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: A systematic review

Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study

Classification of Tumor Epithelium and Stroma by Exploiting Image Features Learned by Deep Convolutional Neural Networks

Management of the toxicities of common targeted therapeutics for gynecologic cancers

The impact of obesity on surgical staging, complications, and survival with uterine cancer: A Gynecologic Oncology Group LAP2 ancillary data study

Prediction of chemotherapy response in ovarian cancer patients using a new clustered quantitative image marker

A contemporary framework of health equity applied to gynecologic cancer care: A Society of Gynecologic Oncology evidenced-based review

Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis

Olaparib: an oral PARP-1 and PARP-2 inhibitor with promising activity in ovarian cancer

Applying Quantitative CT Image Feature Analysis to Predict Response of Ovarian Cancer Patients to Chemotherapy

NRG‐GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer

A contemporary analysis of epidemiology and management of vaginal intraepithelial neoplasia

Potential and mechanism of mebendazole for treatment and maintenance of ovarian cancer

Developing a new radiomics-based CT image marker to detect lymph node metastasis among cervical cancer patients

BRACAnalysis CDx as a companion diagnostic tool for Lynparza

Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma – A multi-institutional cohort

Consideration of older patients for enrollment in phase 1 clinical trials: Exploring treatment related toxicities and outcomes

Primary and acquired platinum-resistance among women with high grade serous ovarian cancer

PARP Inhibition in Ovarian Cancer: State of the Science

Extending the platinum-free interval: The impact of omitting 2nd line platinum chemotherapy in intermediate platinum-sensitive ovarian cancer

Circulating Tumor Cell-Free DNA Genes as Prognostic Gene Signature for Platinum Resistant Ovarian Cancer Diagnosis

The Risk of Umbilical Hernia and Other Complications with Laparoendoscopic Single-Site Surgery

Factors influencing clinical trial enrollment among ovarian cancer patients

Highlights from the Society of Gynecologic Oncology 2015 Annual Meeting on Women's Cancer

Suchergebnisse filtern